Sponsor Pipeline

LaNova Medicines Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
12
Active Trials
9
Recruiting
1
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-31 NCT07669415
A Study of LM-168 Combined With Other Anti-tumor Treatments in Participants With Advanced…
Recruitment opened
Active Trials by Phase
Phase 3
1
Phase 2
3
Phase 1/2
8
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07362186 LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of… Locally Advanced or Metastatic GC and GCJ Adenocarcinoma Recruiting
Phase 2
NCT07387081 Phase II Study of LM-24C5 Advanced Solid Tumor Cancer Recruiting
NCT07669415 A Study of LM-168 Combined With Other Anti-tumor Treatments in Participants With Advanced… Advanced Solid Tumor Recruiting
NCT06873854 A Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours Advanced Solid Tumor Not Yet Recruiting
Phase 1/2
NCT05615974 A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors Malignant Tumors Recruiting
NCT06650566 Study of LM-299 in Subjects Advanced Malignant Tumors Malignant Tumors Recruiting
NCT06187402 A Study of LM-24C5 For Advanced Solid Tumors Advanced Solid Tumor Recruiting
NCT06868199 A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With… Advanced Solid Tumours Recruiting
NCT06682780 A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours Advanced Solid Tumor Recruiting
NCT07112222 A Study of LM-350 in Subjects With Advanced Solid Tumours Malignant Tumors Recruiting
NCT05518045 A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects… Advanced Solid Tumor Active, Not Recruiting
NCT07694765 A Study of LM-364 as a Single Agent or in Combination With Anti-tumor Therapy in Patients… Malignant Tumors Not Yet Recruiting
Get alerts when LaNova Medicines Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free